AfGin Pharma, LLC (the “Company”) is a biopharmaceutical research and development company with unique drug delivery technologies for a number of approved drugs in the health care field. The Company was formed in May 2009 in order to continue these efforts in pre-clinical and clinical development and further explore other categories of central nervous system drugs that would benefit from this drug delivery system. Since formation in 2009, AfGin has extended operations to include a topical Migraine product (Migraderm.com) which is available throughout all states. The company has also formed multiple subsidiaries to capitalize on other consumer markets. The technology and specific agents used within the technology are protected by patents in both North America and major markets throughout the world.